Evogene Financial Results for the Second Quarter of 2018

REHOVOT, Israel, July 18, 2018 (GLOBE NEWSWIRE) — Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it will release its […]